bbsi restriction enzyme (New England Biolabs)
New England Biolabs is a verified supplier 
New England Biolabs manufactures this product 
98
Structured Review
New England Biolabs
bbsi restriction enzyme
Bbsi Restriction Enzyme, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1914 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/program+stata+version+14+statistical+software+program/BbsI/ppr0396850-151-71-74
Average 98 stars, based on 1914 article reviews
Bbsi Restriction Enzyme, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1914 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/program+stata+version+14+statistical+software+program/BbsI/ppr0396850-151-71-74
Average 98 stars, based on 1914 article reviews
bbsi restriction enzyme - by Bioz Stars,
2026-09
98/100 stars
Images
Related Articles
Plasmid Preparation:Article Title: Dipeptidyl peptidase 4 is a cofactor for porcine epidemic diarrhea virus infection Article Snippet: Porcine epidemic diarrhea virus (PEDV) is a member of the genus Alphacoronavirus in the family Coronaviridae, which has a mortality rate of up to 100 % in neonatal piglets and causes huge economic losses to the pig industry.. The target cells of PEDV infection are porcine small intestinal epithelial cells, and the mechanism of PEDV invasion remains unclear.. Our study found that dipeptidyl peptidase 4 (DPP4) acts as a cofactor for PEDV infection by promoting PEDV invasion and replication. Article Title: Artemisinin Suppressed Melanoma Recurrence and Metastasis after Radical Surgery through the KIT/PI3K/AKT Pathway Article Snippet: .. The digestion reaction system was: 2 μg PX459 plasmid, 2 μL 10× NEB buffer 2.1, 1 μL Article Title: Precise template-independent correction of c.1278insTATC frameshift mutation in Tay-Sachs disease restores full gene function while gene reframing yields negligible recovery. Article Snippet: Tay-Sachs disease is a fatal neurodegenerative disorder caused by HEXA mutations inactivating the metabolic enzyme HexA.. The most common mutation is c.1278insTATC, a tandem 4-bp duplication disrupting HEXA expression by frameshift.. In an engineered cell model, we explore the use of CRISPR-Cas9 for therapeutic editing of c.1278insTATC.Within genomic microduplications, the microhomology-mediated end joining (MMEJ) pathway is favored to repair double-stranded breaks with collateral deletion of one repeat. Article Title: KCNN4 as a Genomic Determinant of Cytosolic Delivery by the Attenuated Cationic Lytic Peptide L17E. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Construct:Article Title: Functional evaluation and clinical classification of BRCA2 variants. Article Snippet: .. Multiple sgRNAs were designed using the Benchling design tool. sgRNA-annealed oligonucleotides were ligated into pSpCas9(BB)-2A-Puro (PX459 v.2.0) (Addgene, 62988) following CRISPR:Article Title: KCNN4 as a Genomic Determinant of Cytosolic Delivery by the Attenuated Cationic Lytic Peptide L17E. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Generated:Article Title: KCNN4 as a Genomic Determinant of Cytosolic Delivery by the Attenuated Cationic Lytic Peptide L17E. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Sequencing:Article Title: KCNN4 as a Genomic Determinant of Cytosolic Delivery by the Attenuated Cationic Lytic Peptide L17E. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Ligation:Article Title: KCNN4 as a Genomic Determinant of Cytosolic Delivery by the Attenuated Cationic Lytic Peptide L17E. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. |